Process development and characterization for integrated continuous bioprocesses —Highlights from N‐mAb
AbstractThe N-mAb case study was produced by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to support teaching and learning for both industry and to accelerate adoption of advanced manufacturing process technologies such as integrated continuous bioprocesses (ICB) for mAbs. Similar to the A-mAb case study, N-mAb presents the evolution of an integrated control strategy, from early clinical through process validation and commercial manufacturing with a focus on elements that are unique to integrated continuous bioprocesses. This publication presents a summary of the process design and characterization chapters to allow a greater focus on the unique elements relevant to that phase of development.
Source: Biotechnology Progress - Category: Biotechnology Authors: Kevin Brower,
Kelly Wiltberger,
Claudia Berdugo,
Allen Bosley,
Elizabeth Goodrich,
Valerie Pferdeort,
Gene Schaefer Tags: RESEARCH ARTICLE Source Type: research